GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Median Diagnostics Inc (XKRX:233250) » Definitions » Debt-to-Asset

Median Diagnostics (XKRX:233250) Debt-to-Asset : 0.05 (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Median Diagnostics Debt-to-Asset?

Median Diagnostics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩692 Mil. Median Diagnostics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩521 Mil. Median Diagnostics's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was ₩22,664 Mil. Median Diagnostics's debt to asset for the quarter that ended in Dec. 2024 was 0.05.


Median Diagnostics Debt-to-Asset Historical Data

The historical data trend for Median Diagnostics's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Median Diagnostics Debt-to-Asset Chart

Median Diagnostics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.05 0.05 0.06 0.05

Median Diagnostics Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.05 0.05 0.06 0.05

Competitive Comparison of Median Diagnostics's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Median Diagnostics's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Median Diagnostics's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Median Diagnostics's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Median Diagnostics's Debt-to-Asset falls into.


;
;

Median Diagnostics Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Median Diagnostics's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(692.46 + 520.959) / 22664.488
=0.05

Median Diagnostics's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(692.46 + 520.959) / 22664.488
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Median Diagnostics  (XKRX:233250) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Median Diagnostics Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Median Diagnostics's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Median Diagnostics Business Description

Traded in Other Exchanges
N/A
Address
878 Seoul Office, Dongnae-dong, Kangwon-do, Chuncheon, KOR, 200-883
Median Diagnostics Inc is a Korea based company engaged in providing IVD solutions and veterinary diagnostics services. Its solutions portfolio covers avian influenza diagnosis solution, foot and mouth disease diagnosis solution, African Pig fever solution and others. The company offers ELISA diagnostic products, rapid test kit, molecular diagnosis products, standard diagnosis products and biologicals.

Median Diagnostics Headlines

No Headlines